Update On Mesothelioma Research

The Executive Officer of our organisation, Rose Marie Vojakovic, sought information from Professor Anna Nowak as to the progress of clinical trials. Professor Nowak replied to Rose Marie as follows: “Clinical trials at our centre have recently gone a little too quiet for my liking. We have recently completed enrolling all patients to the FRAME study, which was testing a tablet anti-cancer agent called AZD4547 in people who had previously had standard chemotherapy for mesothelioma.